1. Home
  2. ENGLISH
  3. About us
  4. Corporate Information

Corporate Information

Profile

Name STELLA PHARMA CORPORATION
Established June 1, 2007
Headquarter 3-2-7 Korai-bashi, Chuo-ku, Osaka, Osaka Prefecture 541-0043
Description of business Research, development, manufacturing, and sales of pharmaceuticals
Capital 1.9 billion yen
Shareholders Stella Chemifa, Innovation Network Corporation of Japan, Sumitomo Heavy Industries, Ltd.
Chairman & CEO Tomoyuki Asano
President & COO Koki Uehara
Number of employees 47 (as of June 2020)
Laboratory Sakai R&D Center
Branch Tokyo

History

June 2007 Stella Pharma founded
July 2008 First-class marketing license for pharmaceuticals obtained (Osaka Prefecture)
December 2013 First-class marketing license for medical devices obtained (Osaka Prefecture)
January 2014 The Sanpo and Nakamozu laboratories merged with the Sakai R&D Center
March 2020 Received marketing and manufacturing approval in Japan for STEBORONINE® 9000mg/300mL for infusion for the treatment of locally unresectable recurrent or unresectable advanced head and neck cancer
May 2020 Launched STEBORONINE® 9000mg/300mL for infusion in Japan